AbbVie
Tracked across 7 events · 44 articles · First seen Apr 17, 2025 · Last active May 27, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: AbbVie Inc. is implicated in the lawsuit for its alleged undisclosed interest in acquiring Coeptis Therapeutics Holdings at a higher price than the secondary offering, which supposedly led to an artificially deflated stock price for Coeptis Therapeutics Holdings.
Apr 17, 2025 · 6 articles
Business
Impact: AbbVie Inc. agreed to acquire Coeptis Therapeutics Holdings for $45 per share, a price significantly higher than Coeptis Therapeutics Holdings's secondary offering price, which is central to the alleged securities fraud.
Apr 18, 2025 · 6 articles
Business
Impact: AbbVie Inc. acquired Coeptis Therapeutics Holdings for $45 per share, an acquisition that was allegedly undisclosed during Coeptis Therapeutics Holdings's secondary stock offering, leading to a windfall for Bain Capital, LP.
Apr 18, 2025 · 6 articles
Regulatory
Impact: AbbVie is expected to announce a deal with the Donald Trump administration after the holidays.
Dec 19, 2025 · 7 articles
Business
The biotech sector is experiencing a significant surge in mergers and acquisitions (M&A) in 2026, with deal values already reaching $84 billion in the first quarter, making it the strongest start since 2019. This accelerated…
Impact: AbbVie has experienced changes in senior development and strategy roles, which have influenced its deal negotiations and risk pricing in the current M&A environment.
May 01, 2026 · 6 articles
Tech
Impact: AbbVie Inc. is a funding partner for the project, supporting the research into Alzheimer s disease biomarkers.
Feb 19, 2026 · 6 articles
Bain Capital
unrelated
↔
AbbVie
AbbVie does not have a direct structural or commercial relationship with Bain Ca
Coeptis Therapeutics Holdings
acquirer
↔
AbbVie
AbbVie agreed to acquire Cerevel Therapeutics Holdings for $45 per share in a tr
Coeptis Therapeutics Holdings
target
↔
AbbVie
Cerevel Therapeutics Holdings agreed to be acquired by pharmaceutical giant AbbV
Bain Capital
unrelated
↔
AbbVie
Bain Capital does not have a direct structural or commercial relationship with A
NEWSDESK
Track AbbVie live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard